(Q80170934)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16934196%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Severe skin and soft tissue infections and associated critical illness (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16934196%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16934196%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

John M Embil

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16934196%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16934196%20AND%20SRC:MED&resulttype=core&format=json

Current infectious disease reports

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16934196%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16934196%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16934196%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

375-383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16934196%20AND%20SRC:MED&resulttype=core&format=json

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection

29 December 2019

cites work

1 reference

12 December 2020

M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage

1 reference

12 December 2020

Is plasminogen deployed as a Streptococcus pyogenes virulence factor?

1 reference

12 December 2020

Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection

1 reference

12 December 2020

Uncovering the mysteries of invasive streptococcal diseases

1 reference

12 December 2020

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy

1 reference

12 December 2020

Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis?

1 reference

12 December 2020

Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group

1 reference

12 December 2020

Plasminogen is a critical host pathogenicity factor for group A streptococcal infection

1 reference

12 December 2020

Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group

1 reference

12 December 2020

Clinical and epidemiologic features of methicillin-resistant Staphylococcus aureus in elderly hospitalized patients

1 reference

12 December 2020

In vitro antimicrobial effects of various combinations of penicillin and clindamycin against four strains of Streptococcus pyogenes.

1 reference

12 December 2020

Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review

1 reference

12 December 2020

Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000)

1 reference

12 December 2020

Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections

1 reference

12 December 2020

Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance

1 reference

12 December 2020

Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention

1 reference

12 December 2020

The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence

1 reference

12 December 2020

Streptococcal toxic shock syndrome associated with necrotizing fasciitis

1 reference

12 December 2020

Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?

1 reference

12 December 2020

Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis

1 reference

12 December 2020

Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study

1 reference

12 December 2020

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

1 reference

12 December 2020

Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children

1 reference

12 December 2020

Clinical and Epidemiologic Features of Group A Streptococcal Pneumonia in Ontario, Canada

1 reference

12 December 2020

Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Hospital-acquired invasive group a streptococcal infections in Ontario, Canada, 1992-2000.

1 reference

12 December 2020

Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns

1 reference

12 December 2020

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

12 December 2020

Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach.

1 reference

12 December 2020

New method of classifying infections in critically ill patients

1 reference

12 December 2020

An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections

1 reference

12 December 2020

Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections

1 reference

12 December 2020

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

1 reference

12 December 2020

Rapidly progressive soft tissue infections.

1 reference

12 December 2020

Cellulitis incidence in a defined population

1 reference

12 December 2020

Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?

1 reference

12 December 2020

Macrolide resistance in group A Streptococcus

1 reference

12 December 2020

Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Group A streptococcal infections of the skin: molecular advances but limited therapeutic progress

1 reference

12 December 2020

Invasive group A streptococcal infections in Florida

1 reference

12 December 2020

Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles

1 reference

12 December 2020

Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus

1 reference

12 December 2020

Viable group A streptococci in macrophages during acute soft tissue infection

1 reference

12 December 2020

Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea

1 reference

12 December 2020

Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections

1 reference

12 December 2020

Clinical presentations of soft-tissue infections and surgical site infections

1 reference

12 December 2020

Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci?

1 reference

12 December 2020

Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature

1 reference

12 December 2020

Life-threatening community-acquired methicillin-resistant Staphylococcus aureus infection in Australia.

1 reference

12 December 2020

Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.

1 reference

12 December 2020

Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections

1 reference

12 December 2020

Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infections

1 reference

12 December 2020

Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada

1 reference

12 December 2020

Streptococcal infections of skin and soft tissues

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus disease in three communities

1 reference

12 December 2020

10.1007/S11908-006-0048-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16934196%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference